| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.725 | 0.002 | 0.725 | Glutamate dehydrogenase inhibitor | 0.369 0.004 DBMET01483 | ||
| 0.723 | 0.001 | 0.844 | Histidine decarboxylase inhibitor | 0.844 0.001 DBMET01483 | DBMET01483 | |
| 0.678 | 0.005 | 0.678 | Superoxide dismutase inhibitor | 0.399 0.027 DBMET01483 | ||
| 0.615 | 0.001 | 0.615 | Carboxypeptidase B inhibitor | 0.224 0.002 DBMET01483 | ||
| 0.61 | 0.005 | 0.64 | Psychostimulant | 0.64 0.005 DBMET01483 | DBMET01483 | |
| 0.587 | 0.001 | 0.587 | Carbonic anhydrase stimulant | 0.494 0.002 DBMET01483 | ||
| 0.599 | 0.017 | 0.599 | Immunostimulant | 0.411 0.046 DBMET01483 | ||
| 0.59 | 0.013 | 0.59 | Interleukin antagonist | 0.53 0.017 DBMET01483 | ||
| 0.576 | 0.004 | 0.576 | Thrombolytic | 0.322 0.02 DBMET01483 | ||
| 0.528 | 0.007 | 0.528 | Insulysin inhibitor | 0.456 0.014 DBMET01483 | ||
| 0.521 | 0.004 | 0.86 | GABA C receptor agonist | 0.86 0.001 DBMET01483 | DBMET01483 | |
| 0.518 | 0.005 | 0.59 | Growth hormone agonist | 0.59 0.004 DBMET01483 | DBMET01483 | |
| 0.513 | 0.011 | 0.513 | Angiogenesis stimulant | 0.509 0.011 DBMET01483 | ||
| 0.498 | 0.001 | 0.498 | Carboxypeptidase B2 inhibitor | 0.167 0.002 DBMET01483 | ||
| 0.51 | 0.015 | 0.51 | Antiamyloidogenic | 0.175 0.119 DBMET01483 | ||
| 0.505 | 0.022 | 0.505 | Immunomodulator | 0.222 0.14 DBMET01483 | ||
| 0.461 | 0.013 | 0.461 | Interleukin 2 agonist | 0.426 0.02 DBMET01483 | ||
| 0.422 | 0.003 | 0.422 | Glycine transporter 2 inhibitor | 0.105 0.012 DBMET01483 | ||
| 0.399 | 0.004 | 0.399 | Hematopoietic | 0.236 0.007 DBMET01483 | ||
| 0.416 | 0.034 | 0.617 | Apoptosis antagonist | 0.617 0.008 DBMET01483 | DBMET01483 | |
| 0.399 | 0.019 | 0.399 | Interleukin agonist | 0.304 0.046 DBMET01483 | ||
| 0.382 | 0.008 | 0.382 | Adenylate cyclase inhibitor | 0.15 0.045 DBMET01483 | ||
| 0.37 | 0.003 | 0.37 | Argininosuccinate synthase inhibitor | 0.242 0.005 DBMET01483 | ||
| 0.395 | 0.028 | 0.395 | Platelet antagonist | 0.246 0.074 DBMET01483 | ||
| 0.356 | 0.001 | 0.356 | Lysine carboxypeptidase inhibitor | 0.323 0.001 DBMET01483 | ||
| 0.367 | 0.019 | 0.367 | Anticoagulant | 0.16 0.072 DBMET01483 | ||
| 0.348 | 0.003 | 0.348 | Histamine H3 receptor agonist | 0.317 0.003 DBMET01483 | ||
| 0.362 | 0.032 | 0.362 | Amyloid beta aggregation inhibitor | 0.146 0.111 DBMET01483 | ||
| 0.333 | 0.008 | 0.333 | Cathepsin H inhibitor | 0.136 0.057 DBMET01483 | ||
| 0.327 | 0.011 | 0.327 | Neurotensin receptor agonist | 0.251 0.021 DBMET01483 | ||
| 0.314 | 0.006 | 0.344 | Histone deacetylase SIRT1 inhibitor | 0.344 0.005 DBMET01483 | DBMET01483 | |
| 0.31 | 0.004 | 0.31 | GABA C receptor antagonist | 0.165 0.023 DBMET01483 | ||
| 0.311 | 0.005 | 0.311 | Histone deacetylase class III inhibitor | 0.248 0.01 DBMET01483 | ||
| 0.319 | 0.014 | 0.319 | Hemostatic | |||
| 0.341 | 0.038 | 0.341 | Transcription factor STAT inhibitor | |||
| 0.319 | 0.019 | 0.319 | Peptidyltransferase inhibitor | 0.293 0.027 DBMET01483 | ||
| 0.314 | 0.014 | 0.314 | Neuropeptide Y2 antagonist | 0.302 0.018 DBMET01483 | ||
| 0.299 | 0.003 | 0.299 | GABA C receptor rho-1 antagonist | 0.168 0.015 DBMET01483 | ||
| 0.326 | 0.041 | 0.326 | Transcription factor STAT3 inhibitor | |||
| 0.281 | 0.004 | 0.281 | Bombesin 2 receptor antagonist | 0.184 0.008 DBMET01483 | ||
| 0.275 | 0.01 | 0.275 | Aminopeptidase B inhibitor | 0.273 0.011 DBMET01483 | ||
| 0.291 | 0.035 | 0.291 | Calpain inhibitor | |||
| 0.327 | 0.073 | 0.327 | Antithrombotic | 0.233 0.141 DBMET01483 | ||
| 0.268 | 0.021 | 0.268 | Bone formation stimulant | 0.156 0.054 DBMET01483 | ||
| 0.25 | 0.004 | 0.25 | Adenylate cyclase stimulant | 0.164 0.043 DBMET01483 | ||
| 0.268 | 0.023 | 0.268 | Thiol protease inhibitor | |||
| 0.25 | 0.005 | 0.709 | Ornithine carbamoyltransferase inhibitor | 0.709 0.001 DBMET01483 | DBMET01483 | |
| 0.235 | 0.006 | 0.235 | Folate antagonist | 0.183 0.013 DBMET01483 | ||
| 0.229 | 0.003 | 0.229 | AMPA 1 receptor antagonist | 0.123 0.005 DBMET01483 | ||
| 0.277 | 0.051 | 0.277 | Gastrin inhibitor | |||
| 0.267 | 0.044 | 0.267 | Platelet adhesion inhibitor | |||
| 0.221 | 0.003 | 0.221 | Bombesin antagonist | 0.119 0.005 DBMET01483 | ||
| 0.218 | 0.004 | 0.238 | Bombesin 1 receptor agonist | 0.238 0.004 DBMET01483 | DBMET01483 | |
| 0.215 | 0.004 | 0.215 | Sirtuin 1 inhibitor | 0.205 0.004 DBMET01483 | ||
| 0.219 | 0.009 | 0.219 | Interleukin 8 antagonist | |||
| 0.212 | 0.002 | 0.212 | Carbonic anhydrase I stimulant | 0.133 0.003 DBMET01483 | ||
| 0.224 | 0.014 | 0.237 | Nav1.4 sodium channel blocker | 0.237 0.011 DBMET01483 | DBMET01483 | |
| 0.203 | 0.004 | 0.203 | Renin inhibitor | 0.119 0.005 DBMET01483 | ||
| 0.201 | 0.002 | 0.201 | Carbonic anhydrase II stimulant | 0.118 0.004 DBMET01483 | ||
| 0.214 | 0.018 | 0.214 | Toll-Like receptor 2 antagonist | 0.137 0.062 DBMET01483 | ||
| 0.265 | 0.072 | 0.265 | DNA damaging | |||
| 0.2 | 0.007 | 0.2 | Toll-Like receptor 2 agonist | 0.072 0.018 DBMET01483 | ||
| 0.199 | 0.009 | 0.199 | Antimetabolite | 0.105 0.015 DBMET01483 | ||
| 0.191 | 0.004 | 0.191 | Alpha 2d adrenoreceptor antagonist | 0.095 0.057 DBMET01483 | ||
| 0.188 | 0.004 | 0.188 | Somatostatin 4 agonist | 0.084 0.008 DBMET01483 | ||
| 0.23 | 0.047 | 0.23 | Insulin sensitizer | 0.192 0.082 DBMET01483 | ||
| 0.201 | 0.024 | 0.201 | Cell adhesion inhibitor | 0.113 0.071 DBMET01483 | ||
| 0.235 | 0.063 | 0.235 | Anticonvulsant | |||
| 0.212 | 0.04 | 0.212 | Diuretic | |||
| 0.174 | 0.005 | 0.195 | Glucagon-like peptide 1 agonist | 0.195 0.004 DBMET01483 | DBMET01483 | |
| 0.174 | 0.008 | 0.174 | Neurotensin receptor antagonist | 0.059 0.024 DBMET01483 | ||
| 0.172 | 0.007 | 0.172 | Melanocortin 1 antagonist | 0.092 0.012 DBMET01483 | ||
| 0.188 | 0.024 | 0.188 | Neuropeptide Y1 antagonist | |||
| 0.171 | 0.009 | 0.213 | Histamine N-methyltransferase inhibitor | 0.213 0.005 DBMET01483 | DBMET01483 | |
| 0.175 | 0.014 | 0.177 | Aminoacyl-tRNA synthetase inhibitor | 0.177 0.013 DBMET01483 | DBMET01483 | |
| 0.295 | 0.139 | 0.299 | Antibacterial | 0.299 0.136 DBMET01483 | DBMET01483 | |
| 0.232 | 0.081 | 0.247 | DNA synthesis inhibitor | 0.247 0.068 DBMET01483 | DBMET01483 | |
| 0.163 | 0.013 | 0.163 | Factor V inhibitor | 0.119 0.04 DBMET01483 | ||
| 0.16 | 0.011 | 0.16 | Ribonucleotide reductase inhibitor | 0.156 0.011 DBMET01483 | ||
| 0.278 | 0.129 | 0.278 | Immunosuppressant | |||
| 0.148 | 0.005 | 0.148 | Growth hormone secretagogue receptor antagonist | 0.03 0.028 DBMET01483 | ||
| 0.15 | 0.008 | 0.15 | NMDA receptor agonist | 0.093 0.022 DBMET01483 | ||
| 0.145 | 0.004 | 0.145 | GHS receptor agonist | 0.097 0.005 DBMET01483 | ||
| 0.191 | 0.05 | 0.191 | Phospholipase C inhibitor | 0.184 0.056 DBMET01483 | ||
| 0.151 | 0.013 | 0.166 | Neuropeptide agonist | 0.166 0.009 DBMET01483 | DBMET01483 | |
| 0.149 | 0.011 | 0.149 | Ribonucleoside-diphosphate reductase inhibitor | 0.146 0.012 DBMET01483 | ||
| 0.155 | 0.017 | 0.155 | Selectin antagonist | 0.095 0.029 DBMET01483 | ||
| 0.145 | 0.01 | 0.145 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.143 | 0.009 | 0.143 | Histone deacetylase SIRT2 inhibitor | 0.108 0.023 DBMET01483 | ||
| 0.136 | 0.005 | 0.145 | Farnesyltransferase inhibitor | 0.145 0.005 DBMET01483 | DBMET01483 | |
| 0.188 | 0.063 | 0.241 | Peroxidase inhibitor | 0.241 0.049 DBMET01483 | DBMET01483 | |
| 0.131 | 0.007 | 0.131 | Cathepsin E inhibitor | 0.079 0.023 DBMET01483 | ||
| 0.148 | 0.023 | 0.214 | Nitric-oxide synthase inhibitor | 0.214 0.008 DBMET01483 | DBMET01483 | |
| 0.156 | 0.033 | 0.156 | Chelator | 0.115 0.059 DBMET01483 | ||
| 0.174 | 0.053 | 0.174 | Protein kinase stimulant | |||
| 0.136 | 0.016 | 0.136 | Ornithine decarboxylase inhibitor | 0.126 0.022 DBMET01483 | ||
| 0.14 | 0.022 | 0.14 | Opioid delta receptor antagonist | 0.12 0.026 DBMET01483 | ||
| 0.168 | 0.049 | 0.168 | Cell wall synthesis inhibitor | 0.132 0.084 DBMET01483 | ||
| 0.127 | 0.01 | 0.127 | Melanocortin 3 antagonist | 0.098 0.012 DBMET01483 | ||
| 0.129 | 0.012 | 0.129 | Integrin antagonist | 0.048 0.028 DBMET01483 | ||
| 0.123 | 0.006 | 0.142 | Bombesin 3 receptor antagonist | 0.142 0.004 DBMET01483 | DBMET01483 | |
| 0.122 | 0.006 | 0.122 | Histone deacetylase SIRT3 inhibitor | 0.088 0.014 DBMET01483 | ||
| 0.175 | 0.059 | 0.175 | Catenin beta inhibitor | |||
| 0.119 | 0.005 | 0.119 | Complement C3a chemotactic receptor antagonist | 0.086 0.012 DBMET01483 | ||
| 0.119 | 0.006 | 0.119 | Melanocortin 1 agonist | 0.083 0.009 DBMET01483 | ||
| 0.126 | 0.014 | 0.126 | GP IIb/IIIa receptor antagonist | 0.043 0.039 DBMET01483 | ||
| 0.118 | 0.007 | 0.118 | Calcitonin receptor agonist | 0.118 0.007 DBMET01483 | ||
| 0.128 | 0.02 | 0.144 | Somatostatin 1 agonist | 0.144 0.015 DBMET01483 | DBMET01483 | |
| 0.112 | 0.006 | 0.126 | Melanocortin 5 agonist | 0.126 0.006 DBMET01483 | DBMET01483 | |
| 0.126 | 0.021 | 0.126 | Factor XII inhibitor | 0.086 0.054 DBMET01483 | ||
| 0.134 | 0.03 | 0.134 | Catalase inhibitor | 0.065 0.059 DBMET01483 | ||
| 0.111 | 0.008 | 0.111 | Gonadotropin-releasing hormone receptor agonist | 0.083 0.016 DBMET01483 | ||
| 0.126 | 0.023 | 0.25 | Inducible nitric-oxide synthase inhibitor | 0.25 0.005 DBMET01483 | DBMET01483 | |
| 0.107 | 0.004 | 0.107 | Histamine H2 receptor agonist | 0.106 0.004 DBMET01483 | ||
| 0.149 | 0.047 | 0.149 | Heat shock protein 70 antagonist | |||
| 0.122 | 0.02 | 0.155 | Glutamate decarboxylase inhibitor | 0.155 0.012 DBMET01483 | DBMET01483 | |
| 0.112 | 0.01 | 0.112 | Melanocortin antagonist | 0.079 0.014 DBMET01483 | ||
| 0.122 | 0.02 | 0.122 | CXC chemokine 4 receptor antagonist | 0.1 0.025 DBMET01483 | ||
| 0.113 | 0.012 | 0.113 | Protease activated receptor 1 antagonist | |||
| 0.105 | 0.008 | 0.105 | Somatostatin agonist | 0.059 0.011 DBMET01483 | ||
| 0.098 | 0.002 | 0.098 | Carbonic anhydrase IV stimulant | 0.026 0.005 DBMET01483 | ||
| 0.103 | 0.007 | 0.103 | Cyclin A1 inhibitor | 0.059 0.041 DBMET01483 | ||
| 0.101 | 0.006 | 0.106 | Somatostatin 2 antagonist | 0.106 0.006 DBMET01483 | DBMET01483 | |
| 0.112 | 0.017 | 0.14 | Carbamoyl phosphate synthetase inhibitor | 0.14 0.012 DBMET01483 | DBMET01483 | |
| 0.101 | 0.009 | 0.128 | Histamine agonist | 0.128 0.006 DBMET01483 | DBMET01483 | |
| 0.1 | 0.009 | 0.1 | Angiotensin-converting enzyme inhibitor | 0.069 0.02 DBMET01483 | ||
| 0.129 | 0.041 | 0.129 | Protease inhibitor | 0.084 0.081 DBMET01483 | ||
| 0.098 | 0.01 | 0.098 | Nicotinic receptor alpha3 subunit antagonist | 0.046 0.028 DBMET01483 | ||
| 0.123 | 0.035 | 0.123 | Opioid antagonist | 0.105 0.044 DBMET01483 | ||
| 0.102 | 0.016 | 0.102 | Human rhinovirus A protease inhibitor | |||
| 0.09 | 0.005 | 0.09 | Growth hormone releasing factor agonist | 0.041 0.018 DBMET01483 | ||
| 0.136 | 0.051 | 0.136 | Beta amyloid protein antagonist | |||
| 0.088 | 0.003 | 0.088 | Geranylgeranyltransferase inhibitor | 0.036 0.007 DBMET01483 | ||
| 0.089 | 0.005 | 0.089 | Neurokinin 2 agonist | 0.051 0.018 DBMET01483 | ||
| 0.093 | 0.01 | 0.093 | Melanocortin 4 antagonist | 0.07 0.015 DBMET01483 | ||
| 0.086 | 0.006 | 0.086 | AICAR transformylase inhibitor | 0.049 0.023 DBMET01483 | ||
| 0.085 | 0.005 | 0.105 | Arginase inhibitor | 0.105 0.004 DBMET01483 | DBMET01483 | |
| 0.109 | 0.029 | 0.109 | Cell adhesion molecule inhibitor | |||
| 0.084 | 0.004 | 0.084 | Bombesin 1 receptor antagonist | 0.063 0.007 DBMET01483 | ||
| 0.106 | 0.029 | 0.106 | Opioid mu receptor antagonist | 0.089 0.036 DBMET01483 | ||
| 0.083 | 0.007 | 0.083 | Melanocortin 3 agonist | 0.077 0.008 DBMET01483 | ||
| 0.104 | 0.03 | 0.104 | NMDA 2 receptor antagonist | |||
| 0.083 | 0.009 | 0.083 | Melanocortin agonist | 0.071 0.01 DBMET01483 | ||
| 0.192 | 0.12 | 0.192 | Hypoglycemic | |||
| 0.183 | 0.112 | 0.183 | Free radical scavenger | |||
| 0.099 | 0.029 | 0.099 | Aminopeptidase I inhibitor | 0.075 0.047 DBMET01483 | ||
| 0.078 | 0.008 | 0.078 | Cholecystokinin B agonist | |||
| 0.075 | 0.007 | 0.075 | AMPA 4 receptor antagonist | 0.074 0.007 DBMET01483 | ||
| 0.122 | 0.054 | 0.126 | Photosensitizer | 0.126 0.051 DBMET01483 | DBMET01483 | |
| 0.077 | 0.01 | 0.084 | Somatostatin 1 antagonist | 0.084 0.009 DBMET01483 | DBMET01483 | |
| 0.074 | 0.008 | 0.074 | Integrin alpha5beta1 antagonist | 0.037 0.034 DBMET01483 | ||
| 0.069 | 0.005 | 0.077 | Histamine H1 receptor agonist | 0.077 0.004 DBMET01483 | DBMET01483 | |
| 0.093 | 0.03 | 0.093 | Thrombin inhibitor | 0.066 0.061 DBMET01483 | ||
| 0.076 | 0.013 | 0.087 | Erythropoietin receptor agonist | 0.087 0.012 DBMET01483 | DBMET01483 | |
| 0.071 | 0.012 | 0.071 | Growth hormone release inhibitor | 0.061 0.015 DBMET01483 | ||
| 0.066 | 0.006 | 0.066 | Thrombin receptor antagonist | |||
| 0.071 | 0.013 | 0.071 | Adenosine deaminase inhibitor | 0.067 0.015 DBMET01483 | ||
| 0.067 | 0.009 | 0.076 | Geranyltranstransferase inhibitor | 0.076 0.005 DBMET01483 | DBMET01483 | |
| 0.062 | 0.006 | 0.062 | Dipeptidyl peptidase II inhibitor | 0.046 0.011 DBMET01483 | ||
| 0.122 | 0.067 | 0.122 | DNA polymerase I inhibitor | |||
| 0.06 | 0.005 | 0.06 | GHS receptor antagonist | |||
| 0.081 | 0.026 | 0.081 | Trypsin inhibitor | 0.059 0.05 DBMET01483 | ||
| 0.108 | 0.055 | 0.15 | Adenylate kinase inhibitor | 0.15 0.026 DBMET01483 | DBMET01483 | |
| 0.059 | 0.006 | 0.059 | AMPA 3 receptor antagonist | 0.048 0.01 DBMET01483 | ||
| 0.07 | 0.019 | 0.07 | Metalloproteinase-3 inhibitor | |||
| 0.061 | 0.009 | 0.061 | Melanocortin 4 agonist | 0.044 0.011 DBMET01483 | ||
| 0.071 | 0.02 | 0.071 | AMPA receptor antagonist | 0.055 0.028 DBMET01483 | ||
| 0.076 | 0.026 | 0.076 | Caspase 9 inhibitor | 0.064 0.04 DBMET01483 | ||
| 0.054 | 0.006 | 0.054 | Neurokinin 1 agonist | |||
| 0.051 | 0.005 | 0.051 | Alpha 2d adrenoreceptor agonist | |||
| 0.101 | 0.056 | 0.101 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.05 | 0.005 | 0.05 | Growth hormone release promoting | |||
| 0.108 | 0.063 | 0.108 | Falcipain 3 inhibitor | |||
| 0.051 | 0.007 | 0.051 | Integrin alpha1beta1 antagonist | 0.037 0.03 DBMET01483 | ||
| 0.055 | 0.011 | 0.089 | Glucagon-like peptide 1 receptor antagonist | 0.089 0.005 DBMET01483 | DBMET01483 | |
| 0.094 | 0.051 | 0.094 | NMDA receptor antagonist | |||
| 0.051 | 0.008 | 0.078 | Somatostatin 4 antagonist | 0.078 0.006 DBMET01483 | DBMET01483 | |
| 0.071 | 0.03 | 0.071 | Aminopeptidase microsomal inhibitor | 0.068 0.033 DBMET01483 | ||
| 0.049 | 0.008 | 0.049 | Bradykinin B2 receptor agonist | |||
| 0.054 | 0.014 | 0.054 | Nicotinic receptor beta4 subunit antagonist | 0.038 0.024 DBMET01483 | ||
| 0.059 | 0.019 | 0.059 | Carbonic anhydrase IV inhibitor | |||
| 0.069 | 0.029 | 0.069 | Cathepsin D inhibitor | |||
| 0.052 | 0.012 | 0.061 | Somatostatin 5 antagonist | 0.061 0.01 DBMET01483 | DBMET01483 | |
| 0.046 | 0.008 | 0.046 | Growth hormone releasing factor antagonist | 0.032 0.012 DBMET01483 | ||
| 0.05 | 0.012 | 0.056 | Somatostatin 5 agonist | 0.056 0.01 DBMET01483 | DBMET01483 | |
| 0.051 | 0.014 | 0.051 | Diamine oxidase inhibitor | |||
| 0.073 | 0.037 | 0.073 | Neutrophil collagenase inhibitor | |||
| 0.057 | 0.021 | 0.057 | Cholecystokinin antagonist | |||
| 0.066 | 0.03 | 0.066 | Botulinum neurotoxin type A inhibitor | |||
| 0.044 | 0.01 | 0.044 | Angiotensin II receptor antagonist | |||
| 0.041 | 0.007 | 0.041 | Melatonin 3 antagonist | |||
| 0.094 | 0.06 | 0.094 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.069 | 0.035 | 0.069 | Protease activated receptor antagonist | |||
| 0.171 | 0.141 | 0.171 | Antioxidant | |||
| 0.109 | 0.078 | 0.111 | Alkylator | 0.111 0.076 DBMET01483 | DBMET01483 | |
| 0.035 | 0.006 | 0.035 | Geranylgeranyltransferase I inhibitor | 0.034 0.007 DBMET01483 | ||
| 0.049 | 0.02 | 0.049 | Cholecystokinin A antagonist | |||
| 0.119 | 0.09 | 0.119 | Vanilloid 1 agonist | |||
| 0.095 | 0.067 | 0.095 | Carbonic anhydrase III inhibitor | 0.086 0.081 DBMET01483 | ||
| 0.066 | 0.038 | 0.066 | Nitric oxide donor | |||
| 0.032 | 0.005 | 0.032 | ICAM 1 antagonist | |||
| 0.029 | 0.005 | 0.029 | Angiotensin-converting enzyme 2 inhibitor | 0.018 0.012 DBMET01483 | ||
| 0.028 | 0.003 | 0.028 | Melatonin 5 antagonist | |||
| 0.06 | 0.036 | 0.06 | Cathepsin B inhibitor | |||
| 0.073 | 0.05 | 0.073 | Metalloproteinase-9 inhibitor | |||
| 0.031 | 0.008 | 0.031 | Bombesin agonist | 0.028 0.009 DBMET01483 | ||
| 0.03 | 0.008 | 0.03 | Integrin alphaVbeta3 antagonist | |||
| 0.032 | 0.01 | 0.032 | Vitronectin receptor antagonist | |||
| 0.052 | 0.03 | 0.052 | Aminopeptidase N inhibitor | 0.049 0.032 DBMET01483 | ||
| 0.051 | 0.029 | 0.051 | Endothelin-converting enzyme inhibitor | |||
| 0.047 | 0.026 | 0.073 | Parathyroid hormone antagonist | 0.073 0.006 DBMET01483 | DBMET01483 | |
| 0.062 | 0.042 | 0.062 | NMDA 2C receptor antagonist | |||
| 0.051 | 0.031 | 0.051 | Collagenase inhibitor | |||
| 0.046 | 0.027 | 0.046 | Oxytocin agonist | |||
| 0.054 | 0.034 | 0.054 | NMDA 2A receptor antagonist | |||
| 0.14 | 0.121 | 0.189 | Hepatoprotectant | 0.189 0.073 DBMET01483 | DBMET01483 | |
| 0.058 | 0.04 | 0.058 | Lipocortins synthesis agonist | |||
| 0.051 | 0.033 | 0.051 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.024 | 0.007 | 0.044 | Glucagon agonist | 0.044 0.004 DBMET01483 | DBMET01483 | |
| 0.022 | 0.005 | 0.022 | Integrin alphaVbeta6 antagonist | |||
| 0.048 | 0.032 | 0.048 | Kallikrein inhibitor | |||
| 0.026 | 0.01 | 0.026 | Human T-cell leukemia virus type I protease inhibitor | |||
| 0.034 | 0.018 | 0.039 | Endothelial nitric-oxide synthase inhibitor | 0.039 0.014 DBMET01483 | DBMET01483 | |
| 0.041 | 0.025 | 0.041 | Membrane dipeptidase inhibitor | 0.039 0.027 DBMET01483 | ||
| 0.03 | 0.015 | 0.03 | Melanocortin 5 antagonist | 0.027 0.018 DBMET01483 | ||
| 0.033 | 0.018 | 0.037 | AMPA 2 receptor antagonist | 0.037 0.015 DBMET01483 | DBMET01483 | |
| 0.043 | 0.028 | 0.043 | Angiotensin AT1 receptor antagonist | |||
| 0.032 | 0.018 | 0.032 | Complement C5a chemotactic receptor antagonist | |||
| 0.044 | 0.03 | 0.099 | Glutamate (mGluR4) antagonist | 0.099 0.005 DBMET01483 | DBMET01483 | |
| 0.033 | 0.019 | 0.033 | Cholecystokinin B antagonist | |||
| 0.046 | 0.034 | 0.046 | Plasmin inhibitor | |||
| 0.055 | 0.042 | 0.055 | Kallikrein 1 inhibitor | |||
| 0.055 | 0.043 | 0.055 | Plasminogen activator inhibitor | |||
| 0.033 | 0.022 | 0.1 | Sirtuin 2 inhibitor | 0.1 0.004 DBMET01483 | DBMET01483 | |
| 0.121 | 0.11 | 0.121 | Insulin secretagoues | |||
| 0.022 | 0.012 | 0.027 | Somatostatin 3 antagonist | 0.027 0.01 DBMET01483 | DBMET01483 | |
| 0.028 | 0.018 | 0.028 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.021 | 0.011 | 0.026 | Histamine H4 receptor agonist | 0.026 0.008 DBMET01483 | DBMET01483 | |
| 0.03 | 0.021 | 0.03 | Factor VII inhibitor | |||
| 0.073 | 0.064 | 0.073 | Interferon agonist | 0.073 0.064 DBMET01483 | ||
| 0.031 | 0.022 | 0.031 | Caspase 2 inhibitor | |||
| 0.031 | 0.022 | 0.031 | Bradykinin B2 receptor antagonist | |||
| 0.027 | 0.019 | 0.027 | Urotensin II agonist | 0.025 0.021 DBMET01483 | ||
| 0.016 | 0.009 | 0.016 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | |||
| 0.071 | 0.064 | 0.071 | Metalloproteinase-2 inhibitor | |||
| 0.08 | 0.073 | 0.08 | Falcipain inhibitor | |||
| 0.053 | 0.046 | 0.053 | Cathepsin L inhibitor | |||
| 0.097 | 0.091 | 0.097 | Proteasome inhibitor | |||
| 0.019 | 0.013 | 0.019 | Cholecystokinin agonist | |||
| 0.019 | 0.013 | 0.019 | Bombesin 3 receptor agonist | 0.019 0.013 DBMET01483 | ||
| 0.027 | 0.02 | 0.027 | Vasopressin 1B antagonist | |||
| 0.027 | 0.021 | 0.027 | LFA antagonist | |||
| 0.033 | 0.028 | 0.036 | Opioid delta receptor agonist | 0.036 0.023 DBMET01483 | DBMET01483 | |
| 0.012 | 0.007 | 0.012 | Neurokinin 3 agonist | 0.011 0.008 DBMET01483 | ||
| 0.017 | 0.012 | 0.017 | KiSS-1 receptor antagonist | 0.017 0.013 DBMET01483 | ||
| 0.075 | 0.07 | 0.075 | Glutathione S-transferase inhibitor | |||
| 0.034 | 0.029 | 0.034 | Antibiotic Aminoglycoside-like | |||
| 0.03 | 0.026 | 0.03 | Trypsin I inhibitor | |||
| 0.034 | 0.031 | 0.034 | Tryptase inhibitor | |||
| 0.018 | 0.015 | 0.018 | Integrin alphaVbeta1 antagonist | |||
| 0.007 | 0.005 | 0.007 | Phosphoribosylglycinamide formyltransferase inhibitor | |||
| 0.031 | 0.029 | 0.031 | Calpain 1 inhibitor | |||
| 0.027 | 0.025 | 0.027 | Vasopressin 1A agonist | |||
| 0.107 | 0.105 | 0.107 | DNA repair enzyme inhibitor | |||
| 0.015 | 0.013 | 0.015 | Cholecystokinin A agonist | |||
| 0.016 | 0.014 | 0.016 | Aminopeptidase A inhibitor | |||
| 0.106 | 0.105 | 0.181 | Antibacterial (Helicobacter pylori) | 0.181 0.028 DBMET01483 | DBMET01483 | |
| 0.015 | 0.014 | 0.015 | Protease activated receptor agonist | |||
| 0.037 | 0.036 | 0.037 | VCAM-1 antagonist | |||
| 0.039 | 0.042 | 0.052 | Opioid mu receptor agonist | 0.052 0.028 DBMET01483 | DBMET01483 | |
| 0.052 | 0.057 | 0.056 | Cyclin A2 inhibitor | 0.056 0.05 DBMET01483 | DBMET01483 | |
| 0.046 | 0.051 | 0.065 | Alcohol oxidase inhibitor | 0.065 0.032 DBMET01483 | DBMET01483 | |
| 0.032 | 0.038 | 0.038 | Kainate receptor antagonist | 0.038 0.031 DBMET01483 | DBMET01483 | |
| 0.042 | 0.05 | 0.046 | Opioid agonist | 0.046 0.045 DBMET01483 | DBMET01483 | |
| 0.015 | 0.024 | 0.017 | Tryptophan hydroxylase 1 inhibitor | 0.017 0.013 DBMET01483 | DBMET01483 | |
| 0.031 | 0.041 | 0.039 | Glutamate (mGluR8) antagonist | 0.039 0.019 DBMET01483 | DBMET01483 | |
| 0.067 | 0.079 | 0.134 | GABA B receptor agonist | 0.134 0.005 DBMET01483 | DBMET01483 | |
| 0.056 | 0.073 | 0.277 | Porphobilinogen synthase inhibitor | 0.277 0.006 DBMET01483 | DBMET01483 | |
| 0.171 | 0.196 | 0.214 | Tyrosine 3 hydroxylase inhibitor | 0.214 0.113 DBMET01483 | DBMET01483 | |
| 0.046 | 0.075 | 0.082 | Phosphofructokinase-1 inhibitor | 0.082 0.04 DBMET01483 | DBMET01483 | |
| 0.048 | 0.08 | 0.089 | Phenylalanine 4-hydroxylase inhibitor | 0.089 0.031 DBMET01483 | DBMET01483 | |
| 0.054 | 0.1 | 0.081 | GABA aminotransferase inhibitor | 0.081 0.046 DBMET01483 | DBMET01483 | |
| 0.023 | 0.073 | 0.042 | Glutamate (mGluR3) antagonist | 0.042 0.018 DBMET01483 | DBMET01483 | |
| 0.018 | 0.071 | 0.026 | Motilin receptor antagonist | 0.026 0.023 DBMET01483 | DBMET01483 | |
| 0.03 | 0.083 | 0.043 | Kainate receptor agonist | 0.043 0.024 DBMET01483 | DBMET01483 | |
| 0.043 | 0.107 | 0.078 | Corticotropin releasing factor 2 receptor antagonist | 0.078 0.019 DBMET01483 | DBMET01483 | |
| 0.032 | 0.098 | 0.045 | Histamine H4 receptor antagonist | 0.045 0.041 DBMET01483 | DBMET01483 | |
| 0.062 | 0.132 | 0.081 | NADH dehydrogenase inhibitor | 0.081 0.074 DBMET01483 | DBMET01483 | |
| 0.012 | 0.086 | 0.031 | Kainate receptor 2 antagonist | 0.031 0.029 DBMET01483 | DBMET01483 | |
| 0.057 | 0.133 | 0.14 | Alcohol dehydrogenase inhibitor | 0.14 0.024 DBMET01483 | DBMET01483 | |
| 0.028 | 0.122 | 0.048 | Glutamate (mGluR group III) antagonist | 0.048 0.023 DBMET01483 | DBMET01483 | |
| 0.046 | 0.146 | 0.07 | Glutamate (mGluR6) antagonist | 0.07 0.039 DBMET01483 | DBMET01483 | |
| 0.052 | 0.203 | 0.143 | Lanosterol 14 alpha demethylase inhibitor | 0.143 0.014 DBMET01483 | DBMET01483 | |
| 0.079 | 0.266 | 0.126 | Melanin inhibitor | 0.126 0.123 DBMET01483 | DBMET01483 | |
| 0.136 | 0.352 | 0.189 | 5 Hydroxytryptamine uptake stimulant | 0.189 0.176 DBMET01483 | DBMET01483 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |